ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

M.D. Anderson Wins Nearly $54 Million in ARRA Funding From NIH

November 6, 2009

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

In Brief: Debbie Mayer Elected ONS President; Cullen, Other NCI Staff Honored By Surgeon General

May 15, 1987

Foundation For COG Is New Name Of NCCF.

October 19, 2001

Texts Of Workshop Report Summarized

November 8, 1996